Update shared on 19 Dec 2025
Fair value Increased 0.30%The Analyst Price Target for Amphenol has inched higher to approximately $149 per share from about $148 per share, as analysts point to sustained earnings beats, improving margin outlooks and rising end market demand across autos, hyperscale data centers and broader connectivity applications.
Analyst Commentary
Bullish analysts have broadly raised their price targets on Amphenol following a string of earnings beats and constructive guidance, highlighting both cyclical recovery and structural growth drivers across key end markets.
Recent research updates point to a combination of strong execution, rising estimates and supportive industry data that together underpin the higher valuation framework now being applied to the shares.
Bullish Takeaways
- Bullish analysts are lifting price targets as Q3 results and Q4 guidance came in ahead of expectations, reinforcing confidence in management's ability to consistently outperform Street revenue and EPS forecasts.
- Upward revisions to FY25 revenue and EPS estimates, including moves toward the mid 20 billion dollar range for sales and low 3 dollar EPS, support a higher long term earnings power narrative and justify richer multiples.
- Improving margin outlooks, driven by a mix of accelerated sales growth, favorable end market exposure and scale from recent acquisitions, are seen as important for sustaining double digit earnings growth.
- Positive book to bill trends and stronger medium term demand expectations in autos, connectivity and broader electronics end markets are viewed as tailwinds that could extend Amphenol's current growth cycle into 2026.
Bearish Takeaways
- Bearish analysts maintaining more neutral ratings argue that much of the near term upside from recent beats and guidance raises is increasingly reflected in the stock's valuation.
- Some caution that the pace of end market recovery, particularly in more cyclical segments, could undershoot elevated expectations, creating downside risk to the newly raised estimates.
- There are concerns that integration and execution around large acquisitions, including the sizable CCS division, must remain flawless to avoid margin pressure and dilution to returns.
- Given Amphenol's strong year to date share performance, skeptics see limited multiple expansion potential from here, with future gains more dependent on sustained delivery against the upgraded growth and margin trajectory.
What's in the News
- Truist raised its price target on Amphenol to $147 from $126 and reiterated a Buy rating, citing Q3 earnings upside and margin expansion potential from faster sales growth and favorable end market mix (Periodicals).
- Amphenol completed a major tranche of its share repurchase program, buying back about 13.4 million shares for roughly $1.0 billion under the buyback announced on April 24, 2024 (Key Developments).
- The Board approved a 52% increase in the quarterly dividend to $0.25 per share, payable January 7, 2026 to shareholders of record on December 16, 2025 (Key Developments).
- The company issued strong Q4 2025 and full year 2025 guidance, projecting sales growth of roughly 39% to 41% for Q4 and 49% to 50% for the full year, with GAAP diluted EPS expected between $0.89 and $0.91 for Q4 and $3.31 to $3.33 for the year (Key Developments).
Valuation Changes
- Fair Value has risen slightly, moving from approximately $148.15 to about $148.60 per share, reflecting a modest increase in the intrinsic value estimate.
- Discount Rate has edged down marginally, from roughly 8.52% to 8.52%, signaling a very small decrease in the assumed cost of capital.
- Revenue Growth expectations are essentially unchanged, ticking down fractionally from about 15.47% to 15.47%, indicating stable top line growth assumptions.
- Net Profit Margin has improved very slightly, increasing from roughly 20.57% to 20.57%, pointing to a minimal uplift in long term profitability expectations.
- Future P/E has risen slightly, from about 35.99x to 36.10x, suggesting a modest expansion in the forward valuation multiple applied to earnings.
Have other thoughts on Amphenol?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.
